Rchr
J-GLOBAL ID:200901007636492836
Update date: Oct. 25, 2021
KIYOHIRO ANDO
アンドウ キヨヒロ | KIYOHIRO ANDO
Affiliation and department:
Job title:
Assistant Professor
Research field (1):
Medical biochemistry
Research keywords (1):
The molecular biology of cancer
Research theme for competitive and other funds (2):
- 2018 - 2021 CHK1阻害剤の細胞死誘導の分子機構に着目した感受性遺伝子の同定と臨床応用
- 2018 - 2019 Identifying predicators for therapeutic effect of CHK1 inhibitor in neuroblastoma
Papers (18):
-
Yusuke Ono, Ayumu Sugitani, Hidenori Karasaki, Munehiko Ogata, Reo Nozaki, Junpei Sasajima, Tomoki Yokochi, Shingo Asahara, Kazuya Koizumi, Kiyohiro Ando, et al. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues. MOLECULAR ONCOLOGY. 2017. 11. 10. 1448-1458
-
Kiyohiro Ando, Melissa J. Parsons, Richa B. Shah, Chloe I. Charendoff, Shere L. Paris, Peter H. Liu, Sara R. Fassio, Brittany A. Rohrman, Ruth Thompson, Andrew Oberst, et al. NPM1 directs PIDDosome-dependent caspase-2 activation in the nucleolus. JOURNAL OF CELL BIOLOGY. 2017. 216. 6. 1795-1810
-
Ruth Thompson, Richa B. Shah, Peter H. Liu, Yogesh K. Gupta, Kiyohiro Ando, Aneel K. Aggarwal, Samuel Sidi. An Inhibitor of PIDDosome Formation. MOLECULAR CELL. 2015. 58. 5. 767-779
-
F. Yu, W. Gao, T. Yokochi, Y. Suenaga, K. Ando, M. Ohira, Y. Nakamura, A. Nakagawara. RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma. ONCOGENE. 2014. 33. 20. 2601-2609
-
Lianjie Li, Chuan Shen, Eijiro Nakamura, Kiyohiro Ando, Sabina Signoretti, Rameen Beroukhim, Glenn S. Cowley, Patrick Lizotte, Ella Liberzon, Steven Bair, et al. SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer. CANCER CELL. 2013. 24. 6. 738-750
more...
Lectures and oral presentations (3):
-
Possible therapeutic usage of checkpoint abrogation strategy for neuroblastoma treatment
(第60回日本小児血液・がん学会学術総会 2018)
-
The blockade of DNA damage response increase the sensitivity of CHK1 inhibitor in neuroblastoma
(第77回日本癌学会学術総会 2018)
-
checkpoint abrogationを応用した神経芽腫治療の可能性
(第27回日本癌病態治療研究会 2018)
Education (2):
- 2000 - 2004 Nihon University
- 1992 - 1998 Nihon University 医学部 医学科
Professional career (1):
Work history (2):
- 2017/08/01 - Nihon University School of Medicine Div.of Biochemistry, Dpt. of Biomedical Science Assistant Professor
- Nihon University School of Medicine, Department of Medicine Assistant Professor
Return to Previous Page